Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
CEFADROXIL vs CEFAZOLIN AND DEXTROSE
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: June 2026 · OpiCalc Medical Review Team
Cefadroxil is a first-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), thereby inhibiting transpeptidase activity and disrupting peptidoglycan cross-linking.
Bactericidal agent inhibiting bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), disrupting peptidoglycan cross-linking, leading to cell lysis. Dextrose provides osmotic diuresis and energy source.
Urinary tract infections,Skin and skin structure infections,Pharyngitis,Tonsillitis,Impetigo
Perioperative prophylaxis,Respiratory tract infections,Urinary tract infections,Skin and soft tissue infections,Biliary tract infections,Bone and joint infections,Genital infections,Septicemia,Endocarditis
1-2 g orally once daily or divided into two doses every 12 hours.
1-2 g IV/IM every 8 hours; maximum 12 g/day.
Terminal elimination half-life 1.1-1.5 hours in normal renal function; prolonged to 20-30 hours in end-stage renal disease (Cr Cl <10 m L/min).
1.8 hours (prolonged to 20-40 hours in severe renal impairment, Cr Cl <10 m L/min)
Cefadroxil is not significantly metabolized; it is primarily excreted unchanged in the urine via glomerular filtration and tubular secretion.
Cr Cl 30-59 m L/min: 500 mg every 12 hours; Cr Cl 10-29 m L/min: 500 mg every 24 hours; Cr Cl <10 m L/min: 500 mg every 36 hours.
Cr Cl 30-60 m L/min: 0.5-1 g every 12 hours. Cr Cl <30 m L/min: 0.5-1 g every 24 hours.
No dose adjustment required for hepatic impairment.
No FDA black box warning has been issued for cefadroxil.
Cefadroxil is a first-generation cephalosporin classified as FDA Pregnancy Category B. Animal studies have not demonstrated fetal harm, but no adequate human studies exist. First trimester: Limited data; theoretical risk low. Second and third trimesters: No known teratogenicity; commonly used for UTIs and other infections. Overall, risk is considered low, but use only if clearly needed.
Cefazolin is a first-generation cephalosporin classified as FDA Pregnancy Category B. Animal studies have not demonstrated fetal risk, and there are no adequate, well-controlled studies in pregnant women. However, cephalosporins are generally considered safe during pregnancy. First trimester: Limited data, but no known teratogenic effects. Second and third trimesters: Considered safe; no documented fetal harm. Cefazolin crosses the placenta achieving therapeutic concentrations in fetal serum and amniotic fluid. Overall, risk is low.
Cefadroxil is a first-generation cephalosporin with a long half-life allowing once-daily or twice-daily dosing. It is active against Streptococcus pyogenes and Staphylococcus aureus (MSSA). Use with caution in renal impairment; dose adjustment required for Cr Cl <50 m L/min. Cross-allergenicity with penicillins is possible but low. Can cause false-positive direct Coombs test and urine glucose test if using Clinitest. Avoid in patients with immediate hypersensitivity to cephalosporins.
Cefazolin is a first-generation cephalosporin with activity against gram-positive cocci (except MRSA) and some gram-negative rods. It is often used for surgical prophylaxis. Dextrose solutions may cause hyperglycemia in diabetic patients; monitor blood glucose. Cefazolin has a short half-life (~1.8 hours) and requires dosing adjustment in renal impairment (Cr Cl <55 m L/min). It is compatible with most IV fluids but avoid mixing with calcium-containing solutions in neonates due to precipitation risk. Pain at injection site is common; deep IM administration preferred.
"The serum concentration of Probenecid can be increased when it is combined with Cefadroxil."
"The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Cefadroxil."
"Warfarin may increase the anticoagulant activities of Cefadroxil."
No interactions on record
Common clinical questions about CEFADROXIL vs CEFAZOLIN AND DEXTROSE, answered by our medical review team.
CEFADROXIL is a Cephalosporin Antibiotic that works by Cefadroxil is a first-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), thereby inhibiting transpeptidase activity and disrupting peptidoglycan cross-linking.. CEFAZOLIN AND DEXTROSE is a Cephalosporin Antibiotic that works by Bactericidal agent inhibiting bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), disrupting peptidoglycan cross-linking, leading to cell lysis. Dextrose provides osmotic diuresis and energy source.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between CEFADROXIL and CEFAZOLIN AND DEXTROSE depend on the specific clinical indication. These are both Cephalosporin Antibiotic agents and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of CEFADROXIL is: 1-2 g orally once daily or divided into two doses every 12 hours.. The standard adult dose of CEFAZOLIN AND DEXTROSE is: 1-2 g IV/IM every 8 hours; maximum 12 g/day.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between CEFADROXIL and CEFAZOLIN AND DEXTROSE in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. CEFADROXIL is classified as Category A/B. Cefadroxil is a first-generation cephalosporin classified as FDA Pregnancy Category B. Animal studies have not demonstrated fetal harm, but no adequate human studies exist. First t. CEFAZOLIN AND DEXTROSE is classified as Category A/B. Cefazolin is a first-generation cephalosporin classified as FDA Pregnancy Category B. Animal studies have not demonstrated fetal risk, and there are no adequate, well-controlled st. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.
Cefazolin undergoes minimal hepatic metabolism; majority excreted unchanged in urine via glomerular filtration and tubular secretion. Dextrose undergoes cellular metabolism to carbon dioxide and water.
Primarily renal (90-95% unchanged via glomerular filtration and tubular secretion); minor biliary/fecal (<5%).
Renal (80-90% unchanged via glomerular filtration and tubular secretion); biliary/fecal (<5%)
20% bound to serum proteins (primarily albumin).
80-86% bound to albumin
0.15 L/kg, indicating limited distribution primarily to extracellular fluid.
0.12-0.14 L/kg (primarily extracellular fluid)
Oral: 95-100% (well absorbed from GI tract).
IM: ~100% (rapid and complete absorption)
No adjustment required; primarily renally eliminated. Use standard dosing.
30 mg/kg/day orally divided into two doses every 12 hours; maximum 2 g/day.
25-50 mg/kg/day IV/IM divided every 8 hours; maximum 100 mg/kg/day.
Renal function should be monitored; adjust dose based on creatinine clearance.
Dose based on renal function; consider Cr Cl and adjust per renal guidelines. Typical starting dose: 1 g IV/IM every 12 hours.
None
Cefadroxil absorption is reduced by dairy products (milk, yogurt, cheese) and calcium-fortified foods/juices. Avoid taking with these items. Administer at least 1 hour before or 2 hours after meals to minimize variability, but food does not significantly affect absorption of ceftibuten-like cephalosporins; however, for cefadroxil, food may delay absorption but does not affect total absorption. To ensure consistent absorption, take on an empty stomach if possible.
No specific food interactions. However, patients on parenteral nutrition should be monitored for electrolyte imbalances. Dextrose content may affect blood glucose; adjust diabetic diet accordingly.
Cefadroxil is excreted into breast milk in small amounts (M/P ratio not established, but likely <1). It is considered compatible with breastfeeding by the American Academy of Pediatrics. Monitor infant for diarrhea, candidiasis, or allergic reaction.
Cefazolin is excreted into breast milk in low concentrations (M/P ratio approximately 0.02-0.03). The American Academy of Pediatrics considers cefazolin compatible with breastfeeding due to poor oral bioavailability in infants. Adverse effects in breastfed infants are rare. Clinical monitoring for diarrhea or rash in the infant is recommended.
Pregnancy induces increased plasma volume and glomerular filtration rate, potentially increasing clearance of cephalosporins. For severe infections, consider dose adjustment (e.g., higher doses or more frequent administration). Standard dosing (e.g., 1-2 g/day) may be insufficient; some sources recommend standard dosing unless renal impairment. Monitor clinical response.
Pregnancy-related physiological changes (increased plasma volume, enhanced renal clearance) may reduce serum concentrations of cefazolin. For surgical prophylaxis during cesarean section, standard dose is 1-2 g IV after cord clamping, with no adjustment needed. For treatment of infections in pregnancy, standard adult dosing is appropriate, but consider increased clearance; some guidelines suggest a higher frequency dosing (e.g., every 6 hours instead of every 8 hours) for severe infections due to increased volume of distribution and renal elimination. Monitor clinical response and consider serum levels if available. No dose reduction required.
Take exactly as prescribed, even if you feel better. Complete the full course.,Do not take with dairy products (milk, yogurt, cheese) or calcium-fortified juices; space by at least 2 hours.,May cause diarrhea; contact your doctor if watery or bloody stools occur.,Notify your doctor of any rash, itching, or difficulty breathing.,Store at room temperature, away from moisture and heat.
Take this medication exactly as prescribed; complete the full course even if you feel better.,Report any signs of allergic reaction: rash, hives, itching, difficulty breathing, or swelling of face/throat.,If you have diabetes, monitor blood glucose closely as the dextrose solution may increase blood sugar.,This medication may cause diarrhea; if severe or bloody, contact your doctor immediately.,Inform your healthcare provider if you have kidney disease, colitis, or allergies to penicillins or cephalosporins.